Table of ContentsView AllTable of ContentsHow Is Ketamine Different From Opioids?Approved Uses and Legal StatusKetamine for Chronic PainSide Effects
Table of ContentsView All
View All
Table of Contents
How Is Ketamine Different From Opioids?
Approved Uses and Legal Status
Ketamine for Chronic Pain
Side Effects
Ketamineis not an opioid. However, it can sometimes be mistaken for one because of the similarities between the two types of drugs.
Like opioids, ketamine does cause sedation (a relaxed and sleepy state). It can also produce dissociative feelings, hallucinations, and amnesia (no memory of events while under the influence of the drug). It is also similar to opioids in that it has ahigh abuse potential.For that reason, it is a controlled substance.
Ketamine is a non-barbiturate generalanestheticand anNMDAreceptor antagonist. It is available as an injectable drug, ketamine hydrochloride, approved for anesthesia in diagnostic and surgical procedures–both alone or in combination with other anesthetic drugs.
Spravato is another ketamine product that contains just one of the two forms of ketamine’s chemical structure, called esketamine, and is a nasal spray approved for treating depression in adults.
This article will discuss the differences between ketamine and opioids, ketamine’s uses and legal status, and safety considerations for ketamine.
Getty Images / RJ Sangosti / MediaNews Group / The Denver Post via Getty Images / Contributor
While ketamine shares some characteristics withopioids, such as producing sleepiness and having a potential for abuse, it is a different type of drug from opioids.
Is Ketamine a Controlled Substance?
Ketamine is a Schedule III (3) controlled substance.
Understanding Ketamine: Approved Uses and Legal Status
The DEA uses Schedules I through V to classify the risk and abuse potential of different drugs, as well as set laws for how tightly different drugs need to be regulated.
Schedule I drugs carry the highest risk of abuse and dependence and are not approved for any medical use. An example of a Schedule I drug is heroin.
Schedule V drugs carry the lowest abuse potential and come with the fewest amount of restrictions, with examples including Lyrica (pregabalin) and some cough medicine products that contain codeine.
Ketamine is classified right in the middle of this scale at a Schedule III, meaning the DEA considers it to carry a moderate to low risk of dependence. The drug does get abused and sold illegally as a street drug.
If you are about to undergo a surgical procedure, either in an outpatient setting or while hospitalized, your healthcare provider administering anesthesia will discuss the medications they plan to use to keep you comfortable and asleep throughout your procedure. This list of drugs may include ketamine. Hospitals and clinics take measures to comply with controlled substance laws, so this is nothing you need to worry about.
Your pharmacy may also practice necessary restrictions if a healthcare provider prescribes you Spravato, the nasal spray containing esketamine, similar to ketamine hydrochloride. The number of refills you can get of this medication within a certain period of time will be restricted depending on the state you live in.
Pharmacies in almost every state also use PDMP, or prescription drug monitoring programs. These programs prevent people from filling controlled substances at different pharmacies repeatedly in a short period. They enable all different pharmacies to see where people have filled controlled substances at other pharmacies and can deny filling the prescription if they feel there are signs of abuse or overuse of controlled substances, including ketamine.
The United States (U.S.) Food and Drug Administration (FDA) has not approved ketamine as a pain treatment. However, it is often used off-label for this purpose.
Lower dosing of ketamine is used in pain treatment compared to that needed for surgical procedures to prevent dissociative or other psychological effects that may come with higher dosing.
For this reason, ketamine has a high potential for pain management as an alternative to opioids. It is already commonly used off-label for acute or extreme pain seen in emergency departments, such as trauma, fractures, and abdominal or flank pain. Off-label use for treating chronic pain is not unusual either.
What Does “Off-Label” Use Mean?“Off-label” use is the practice of prescribing FDA-approved medications for a health condition or disease that it is not approved for. This happens when a healthcare provider deems the drug medically appropriate for a particular individual and their condition.Drugs used off-label may be given for a disease or condition they are not approved to treat, given in a different form, or prescribed in a different dose than what is FDA-approved.
What Does “Off-Label” Use Mean?
“Off-label” use is the practice of prescribing FDA-approved medications for a health condition or disease that it is not approved for. This happens when a healthcare provider deems the drug medically appropriate for a particular individual and their condition.Drugs used off-label may be given for a disease or condition they are not approved to treat, given in a different form, or prescribed in a different dose than what is FDA-approved.
“Off-label” use is the practice of prescribing FDA-approved medications for a health condition or disease that it is not approved for. This happens when a healthcare provider deems the drug medically appropriate for a particular individual and their condition.
Drugs used off-label may be given for a disease or condition they are not approved to treat, given in a different form, or prescribed in a different dose than what is FDA-approved.
Guidance on Ketamine’s Off-Label Use
Some organizations that have contributed to these guidelines that will help other providers safely treat pain with ketamine include the:
These groups recognize that more thorough and consistent research is needed. However, they do their best with existing research data to provide standardized recommendations on dosing, indications (uses), pretreatment requirements, necessary personnel to administer infusions, and what indicates a positive treatment response.
The committees only assert weak or no evidence for improvement in pain types such as:
Guidelines also assert that ketamine should not be used if you:
More research is needed on the types of pain that ketamine is most effective in treating and the appropriate dosing and criteria for treating these types of pain.
Side Effects and Risks of Ketamine
Some more common side effects of ketamine include:
Other possible but less common side effects or risks that can come with ketamine include:
Summary
Ketamine is not an opioid, but it does share some similarities with the opioid drug class, including its ability to cause sedation and respiratory depression and its tendency to be abused or overused.
Like opioids, it is also a controlled substance. However, it is a Schedule III controlled substance, while most opioids are Schedule II because they carry a higher risk of abuse and dependence.
Because of this analgesic effect, ketamine has started to be widely used for treating pain despite not having FDA approval for any pain indication.
Based on existing but limited research data, ketamine holds some promise as an alternative pain management treatment. Still, more thorough and consistent research is needed.
8 SourcesVerywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Drug Enforcement Administration.Ketamine.Food and Drug Administration.Ketalar label.Food and Drug Administration.Spravato label.Maja Djurendic-Brenesel, Vladimir Pilija.Opiate receptors and gender and relevance to heroin addiction, neuropathology of drug addictions and substance misuse.Academic Press. 2016;(86):922-932.Cohen SP, Bhatia A, Buvanendran A, et al.Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Reg Anesth Pain Med. 2018;43(5):521-546.DEA.Drug scheduling.Haffajee RL, Mello MM, Zhang F, et al.Four states with robust prescription drug monitoring programs reduced opioid dosages.Health Aff. 2018;37(6):964-974. doi:10.1377/hlthaff.2017.1321Food and Drug Administration.Understanding unapproved use of approved drugs “off label”.
8 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Drug Enforcement Administration.Ketamine.Food and Drug Administration.Ketalar label.Food and Drug Administration.Spravato label.Maja Djurendic-Brenesel, Vladimir Pilija.Opiate receptors and gender and relevance to heroin addiction, neuropathology of drug addictions and substance misuse.Academic Press. 2016;(86):922-932.Cohen SP, Bhatia A, Buvanendran A, et al.Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Reg Anesth Pain Med. 2018;43(5):521-546.DEA.Drug scheduling.Haffajee RL, Mello MM, Zhang F, et al.Four states with robust prescription drug monitoring programs reduced opioid dosages.Health Aff. 2018;37(6):964-974. doi:10.1377/hlthaff.2017.1321Food and Drug Administration.Understanding unapproved use of approved drugs “off label”.
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Drug Enforcement Administration.Ketamine.Food and Drug Administration.Ketalar label.Food and Drug Administration.Spravato label.Maja Djurendic-Brenesel, Vladimir Pilija.Opiate receptors and gender and relevance to heroin addiction, neuropathology of drug addictions and substance misuse.Academic Press. 2016;(86):922-932.Cohen SP, Bhatia A, Buvanendran A, et al.Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Reg Anesth Pain Med. 2018;43(5):521-546.DEA.Drug scheduling.Haffajee RL, Mello MM, Zhang F, et al.Four states with robust prescription drug monitoring programs reduced opioid dosages.Health Aff. 2018;37(6):964-974. doi:10.1377/hlthaff.2017.1321Food and Drug Administration.Understanding unapproved use of approved drugs “off label”.
Drug Enforcement Administration.Ketamine.
Food and Drug Administration.Ketalar label.
Food and Drug Administration.Spravato label.
Maja Djurendic-Brenesel, Vladimir Pilija.Opiate receptors and gender and relevance to heroin addiction, neuropathology of drug addictions and substance misuse.Academic Press. 2016;(86):922-932.
Cohen SP, Bhatia A, Buvanendran A, et al.Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Reg Anesth Pain Med. 2018;43(5):521-546.
DEA.Drug scheduling.
Haffajee RL, Mello MM, Zhang F, et al.Four states with robust prescription drug monitoring programs reduced opioid dosages.Health Aff. 2018;37(6):964-974. doi:10.1377/hlthaff.2017.1321
Food and Drug Administration.Understanding unapproved use of approved drugs “off label”.
Meet Our Medical Expert Board
Share Feedback
Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit
Was this page helpful?
Thanks for your feedback!
What is your feedback?OtherHelpfulReport an ErrorSubmit
What is your feedback?
